[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-365910-105":59,"doc-detail-365910-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","extracellular-vesicles-the-trojan-horse-within-breast-cancer-host-microenvironments","Extracellular vesicles - the “Trojan Horse” within breast cancer host microenvironments","","Breast cancer remains a major global health burden for women, with metastasis-driven pathways underlying difficult prognoses. Extracellular vesicles (EVs) are phospholipid-bilayer membrane structures secreted by many cell types, carrying diverse lipids, proteins, nucleic acids, and metabolites. In the tumor microenvironment (TME), EVs act as a “Trojan Horse,” shaping tumor initiation, progression, metastasis, and therapeutic responses. EVs from tumor cells and TME-associated entities promote angiogenesis, establish pre-metastatic niches, drive invasive and immune-evasive phenotypes, and contribute to chemotherapy resistance, while their biocompatibility supports EV-based drug delivery potential. The article reviews pathogenic mechanisms and prospective therapeutic strategies to support precision-guided breast cancer interventions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/extracellular-vesicles-the-trojan-horse-within-breast-cancer-host-microenvironments/365910/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/extracellular-vesicles-the-trojan-horse-within-breast-cancer-host-microenvironments/365910.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are extracellular vesicles (EVs) and what do they contain?","Question",{"text":112,"@type":113},"EVs are membrane-bound structures with phospholipid bilayers secreted by many cell types. Their cargo includes lipids, proteins, nucleic acids, and cellular metabolites.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do EVs influence breast cancer within the tumor microenvironment (TME)?",{"text":117,"@type":113},"Within the TME, EVs function like a “Trojan Horse,” affecting tumor initiation, progression, metastasis, and responses to therapy. They can promote angiogenesis, create pre-metastatic niches, and help cancer cells acquire invasion, immune evasion, and metastasis traits.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are EVs considered promising for therapeutic drug delivery?",{"text":121,"@type":113},"EVs can traverse biological barriers due to their biocompatibility, which supports their potential as innovative drug delivery vehicles. This may help address limitations of traditional cancer treatments.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},365910,1790872487,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Kang et al. Molecular Cancer (2025) 24:183 [https://doi.org/10.1186/s12943-025-02358-y](https://doi.org/10.1186/s12943-025-02358-y)  \nMolecular Cancer  \n REVIEW Open Access  \nExtracellular vesicles: the “Trojan Horse”  \nwithin breast cancer host microenvironments  \nYue Kang1†, Ling’ao Meng1†, Shi Bai2* and Shenglong Li3,4,5,6*  \nAbstract  \nBreast cancer represents a significant global health concern among women. The intricate processes and pathways underlying metastasis contribute to the challenging prognoses experienced by some patients. Extracellular vesicles (EVs) are membrane-bound structures characterized by phospholipid bilayers, capable of secretion by a multitude of cell types. The contents of these vesicles encompass a diverse assortment of lipids, proteins, nucleic acids, and cellular metabolites. The tumor microenvironment (TME) comprises a complex network involving tumor cells, noncancerous cells, and an array of molecules they generate and release. Components include the extracellular matrix, cancer-associated fibroblasts, inflammatory immune cells, tumor-associated vasculature, and EVs discharged by these cellular entities. Within the TME, EVs serve as a mechanism akin to the “Trojan Horse,” exerting significant influence in tumor initiation, progression, metastasis, and responses to therapeutic interventions. EVs originating from tumor cells and associated entities within the TME bolster processes such as stimulating angiogenesis adjacent to tumor sites, establishing pre-metastatic niches in distant anatomical regions, and inducing transformative changes in cancer cells to acquire characteristics promoting invasion, angiogenesis, immune evasion, distant metastasis, and resistance to chemotherapy. Noteworthy is the unique capacity of EVs to traverse biological barriers due to their inherent biocompatibility, rendering them promising candidates for innovative drug delivery systems. This attribute presentsan avenue to surmount the constraints of traditional cancer treatments. This scholarly inquiry delves into the pathogenic mechanisms of EVs in breast cancer and delves into prospective therapeutic interventions, offering a groundwork for forthcoming precision-guided therapies tailored to breast cancer.  \nKeywords Breast cancer, Extracellular vesicles, Metastasis, Pre-metastatic niche, Tumor microenvironment, Drug resistance, Drug delivery vehicles  \n†Yue Kang and Ling’ao Meng contributed equally to this work.  \n*Correspondence: Shi Bai [baishi@sut.edu.cn](baishi@sut.edu.cn)[ ](baishi@sut.edu.cn)Shenglong Li  \n[lishenglong@cancerhosp-ln-cmu.com](lishenglong@cancerhosp-ln-cmu.com); [slli@cmu.edu.cn](slli@cmu.edu.cn); lishenglong@ [dlut.edu.cn](dlut.edu.cn)  \n1 Department of Breast Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province 110042, China  \n2 School of Science and Engineering, Shenyang University of Technology, Shenyang, Liaoning Province 110870, China  \n3 Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China  \n4 State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, China  \n5 Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, Fujian, China  \n6 Institute of Cancer Medicine, Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning 116024, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have pe","cbCait5P8SGfLia7","https://ap.wps.com/l/cbCait5P8SGfLia7","pdf",5531092,23,"English","# Abstract\n# Introduction\n## Breast cancer burden and clinical challenge\n## Tumor microenvironment components and interactions\n## Review focus and EV role in metastasis","[{\"question\":\"What are extracellular vesicles (EVs) and what do they contain?\",\"answer\":\"EVs are membrane-bound structures with phospholipid bilayers secreted by many cell types. Their cargo includes lipids, proteins, nucleic acids, and cellular metabolites.\"},{\"question\":\"How do EVs influence breast cancer within the tumor microenvironment (TME)?\",\"answer\":\"Within the TME, EVs function like a “Trojan Horse,” affecting tumor initiation, progression, metastasis, and responses to therapy. They can promote angiogenesis, create pre-metastatic niches, and help cancer cells acquire invasion, immune evasion, and metastasis traits.\"},{\"question\":\"Why are EVs considered promising for therapeutic drug delivery?\",\"answer\":\"EVs can traverse biological barriers due to their biocompatibility, which supports their potential as innovative drug delivery vehicles. This may help address limitations of traditional cancer treatments.\"}]","Extracellular vesicles - the “Trojan Horse” within breast cancer host microenvironments | PDF",1790162902,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45f9cb0fac437a89fa28740b43eb490d.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a160b19494432f2c262a2cdf3719b9f.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6369636d735a515f61413a38d436f48a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9532846624cbb306e323ae745f28d393.webp",980,1301]